相关实验视频

Updated: May 16, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

努西费林通过HSP90AA1在小鼠中减轻癌症和白血病引起的肌肉损耗

Xueyan An¹, Lisha Ma¹, Yulan Bai¹

¹Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, College of Pharmacy, Shihezi University, Shihezi, China.

Journal of cachexia, sarcopenia and muscle

|April 2, 2025

概括

努西费林 (NF) 通过向HSP90AA1.1,有效地对抗癌症缓解症引起的肌肉缩. 这种化合物调节关键信号通路,为这种严重疾病提供了潜在的新疗法.

科学领域:

生物化学生化学
药理学药理学是指药理学的学科.
在瘤学瘤学.

背景情况:

癌症 (CC) 影响80%的晚期癌症患者,目前没有FDA批准的治疗方法.
从莲花叶中提取的努西费林 (NF) 具有抗炎和抗瘤的特性.
了解NF对CC诱导的肌肉缩的机制对于治疗的发展至关重要.

研究的目的:

研究努西费林 (NF) 的分子标和机制,以预防癌症缓解症诱导的肌肉缩.
为了验证NF在癌症缓解症的动物模型中的疗效.
为了确定参与减轻肌肉损耗的NF的特定蛋白质标.

主要方法:

建立了癌症缓冲症的动物模型,以评估NF对肌肉功能和组织学的影响.
网络药理学和分子对接被用来预测NF的目标和机制.
西方涂抹,分子动力学模拟,DARTS和SPR被用来验证NF与其关键目标的相互作用.

主要成果:

在卡塞克斯小鼠中,NF治疗显著改善了握力,悬挂时间,肌肉重量和肌肉纤维横截面积.
NF降低了髓重链降解和Atrogin1和MuRF1的水平,这是关键的肌肉消耗E3链酶.
网络药理学确定AKT1,TNF和HSP90AA1为主要目标,调节PI3K-Akt和炎症途径. 证实HSP90AA1是NF的直接目标.

结论:

努西费林 (NF) 有效地减轻癌症缓解症引起的肌肉缩.
NF通过直接结合HSP90AA1而起作用,调节AKT-mTOR和NF-κB信号通路.
作为治疗癌症缓解症的治疗剂,NF显示出显著的潜力.

关键词:

这就是阿克特姆托尔.在HSP90AA1AA1中使用.在 NF-κBB 中.癌症缓解症,肌肉消耗,肌肉消耗.核胺是一种核胺.

更多相关视频

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse

Published on: May 31, 2016

相关概念视频

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...